01 1Catalent Micron Technologies, Inc.
02 2Lonza AG
01 1Vandetanib
02 1vandetanib
03 1vandetanib non-mc
01 3U.S.A
NDC Package Code : 69988-0054
Start Marketing Date : 2011-04-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 49187-0221
Start Marketing Date : 2021-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49187-0220
Start Marketing Date : 2016-07-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A VANDETANIB manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of VANDETANIB, including repackagers and relabelers. The FDA regulates VANDETANIB manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. VANDETANIB API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of VANDETANIB manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A VANDETANIB supplier is an individual or a company that provides VANDETANIB active pharmaceutical ingredient (API) or VANDETANIB finished formulations upon request. The VANDETANIB suppliers may include VANDETANIB API manufacturers, exporters, distributors and traders.
click here to find a list of VANDETANIB suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing VANDETANIB as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for VANDETANIB API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture VANDETANIB as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain VANDETANIB and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a VANDETANIB NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of VANDETANIB suppliers with NDC on PharmaCompass.
We have 2 companies offering VANDETANIB
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
